Literature DB >> 10985766

Interactions of conformationally biased north and south 2'-fluoro-2', 3'-dideoxynucleoside 5'-triphosphates with the active site of HIV-1 reverse transcriptase.

L Mu1, S G Sarafianos, M C Nicklaus, P Russ, M A Siddiqui, H Ford, H Mitsuya, R Le, E Kodama, C Meier, T Knispel, L Anderson, J J Barchi, V E Marquez.   

Abstract

Molecular dynamics simulations of a ternary complex of HIV-1 reverse transcriptase (RT), double-stranded DNA, and bound dideoxynucleoside-5'-triphosphate (RT-DNA-ddNTP), utilizing the ddNTPs ddATP, betaFddATP, and alphaFddATP, explain the experimentally observed order of potency of these 5'-triphosphates as inhibitors of RT: ddATP > betaFddATP > alphaFddATP. On the basis of RT's known preference to bind the incoming dNTP (or ddNTP) with a north conformation at the polymerase site, alphaFddATP, which in solution prefers almost exclusively a north conformation, was predicted to be the most potent inhibitor. However, Tyr115, which appears to function as a steric gate to preclude the binding of ribonucleoside 5'-triphosphates, prevents the effective binding of alphaFddATP in its preferred north conformation. The south-biased betaFddATP, while able to bind to RT without hindrance by Tyr115, has to pay a high energy penalty to be flipped to the active north conformation at the polymerase site. Finally, the more flexible and less conformationally biased ddATP is able to switch to a north conformation at the RT site with a smaller energy penalty than betaFddATP. These results highlight the opposite conformational preferences of HIV-1 RT for alphaFddATP and betaFddATP and help establish conformational guidelines for optimal binding at the polymerase site of this enzyme.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10985766     DOI: 10.1021/bi001090n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  The sugar ring conformation of 4'-ethynyl-2-fluoro-2'-deoxyadenosine and its recognition by the polymerase active site of HIV reverse transcriptase.

Authors:  K A Kirby; K Singh; E Michailidis; B Marchand; E N Kodama; N Ashida; H Mitsuya; M A Parniak; S G Sarafianos
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2011-02-12       Impact factor: 1.770

2.  Reverse transcriptase incorporation of 1,5-anhydrohexitol nucleotides.

Authors:  K Vastmans; M Froeyen; L Kerremans; S Pochet; P Herdewijn
Journal:  Nucleic Acids Res       Date:  2001-08-01       Impact factor: 16.971

3.  Selective modulation of DNA polymerase activity by fixed-conformation nucleoside analogues.

Authors:  Robert L Eoff; Colleen E McGrath; Leena Maddukuri; S Giovanna Salamanca-Pinzón; Victor E Marquez; Lawrence J Marnett; F Peter Guengerich; Martin Egli
Journal:  Angew Chem Int Ed Engl       Date:  2010-10-04       Impact factor: 15.336

4.  Nucleotide Sugar Pucker Preference Mitigates Excision by HIV-1 RT.

Authors:  Ken Yamada; Alexander S Wahba; Jean A Bernatchez; Tatiana Ilina; Saúl Martínez-Montero; Maryam Habibian; Glen F Deleavey; Matthias Götte; Michael A Parniak; Masad J Damha
Journal:  ACS Chem Biol       Date:  2015-07-22       Impact factor: 5.100

5.  Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase.

Authors:  Kamalendra Singh; Bruno Marchand; Karen A Kirby; Eleftherios Michailidis; Stefan G Sarafianos
Journal:  Viruses       Date:  2010-02-11       Impact factor: 5.048

6.  Effects of substitutions at the 4' and 2 positions on the bioactivity of 4'-ethynyl-2-fluoro-2'-deoxyadenosine.

Authors:  Karen A Kirby; Eleftherios Michailidis; Tracy L Fetterly; Musetta A Steinbach; Kamalendra Singh; Bruno Marchand; Maxwell D Leslie; Ariel N Hagedorn; Eiichi N Kodama; Victor E Marquez; Stephen H Hughes; Hiroaki Mitsuya; Michael A Parniak; Stefan G Sarafianos
Journal:  Antimicrob Agents Chemother       Date:  2013-10-07       Impact factor: 5.191

7.  Nucleotide modification at the gamma-phosphate leads to the improved fidelity of HIV-1 reverse transcriptase.

Authors:  Brent A Mulder; Steve Anaya; Peilin Yu; Keun Woo Lee; Anvy Nguyen; Jason Murphy; Richard Willson; James M Briggs; Xiaolian Gao; Susan H Hardin
Journal:  Nucleic Acids Res       Date:  2005-09-01       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.